These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33966175)

  • 1. Deciphering the nexus between the tumor immune microenvironment and DNA methylation in subgrouping estrogen receptor-positive breast cancer.
    Chen XQ; Zhang F; Xiao FH; Peng Y
    Breast Cancer; 2021 Nov; 28(6):1252-1260. PubMed ID: 33966175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype.
    Chen XQ; Zhang F; Su QC; Zeng C; Xiao FH; Peng Y
    Clin Epigenetics; 2020 Jan; 12(1):16. PubMed ID: 31959227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
    Xiao R; Yang M; Tan Y; Ding R; Li D
    Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.
    Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H
    Front Immunol; 2021; 12():657950. PubMed ID: 33936088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma.
    He Q; Xue S; Wa Q; He M; Feng S; Chen Z; Chen W; Luo X
    Medicine (Baltimore); 2021 Apr; 100(17):e25715. PubMed ID: 33907159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer.
    Wang J; Yang Z; Zhang C; Ouyang J; Zhang G; Wu C
    Gene; 2020 Nov; 761():145049. PubMed ID: 32791092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic implications and tumor-suppressive functions of CYR61 in estrogen receptor-positive breast cancer.
    Zhang C; Li Z; Hu K; Ren Y; Zhang H; Zhao Y; Wei W; Tu S; Yan X
    Front Immunol; 2023; 14():1308807. PubMed ID: 38259466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERĪ±-negative breast tumorigenesis.
    Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
    BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer.
    Teschendorff AE; Miremadi A; Pinder SE; Ellis IO; Caldas C
    Genome Biol; 2007; 8(8):R157. PubMed ID: 17683518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression patterns associated with tumor-infiltrating CD4+ and CD8+ T cells in invasive breast carcinomas.
    Wang Z; Yang X; Shen J; Xu J; Pan M; Liu J; Han S
    Hum Immunol; 2021 Apr; 82(4):279-287. PubMed ID: 33612391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing the role of BRCA1 in the diagnosis, prognosis and immune infiltrates of breast invasive cancer by bioinformatics analysis and experimental validation.
    Li L; Li S; Zhang X; Mei L; Fu X; Dai M; Wei N
    Aging (Albany NY); 2024 Jan; 16(2):1077-1095. PubMed ID: 38224491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis.
    Chen H; Liu Y; Yin Z; Chen H; Wang Y; Qian Y
    Cell Cycle; 2023 May; 22(9):1077-1100. PubMed ID: 36757135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression and DNA methylation analyses suggest that immune process-related ADCY6 is a prognostic factor of luminal-like breast cancer.
    Li W; Sang M; Hao X; Jia L; Wang Y; Shan B
    J Cell Biochem; 2020 Jul; 121(7):3537-3546. PubMed ID: 31886586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment.
    Chen Y; Meng Z; Zhang L; Liu F
    Front Immunol; 2021; 12():664845. PubMed ID: 33968066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
    Song C; Shang F; Tu W; Liu X
    BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Breast Cancer Subtypes Based on Endoplasmic Reticulum Stress-Related Genes and Analysis of Prognosis and Immune Microenvironment in Breast Cancer Patients.
    Yi C; Yang J; Zhang T; Qin L; Chen D
    Technol Cancer Res Treat; 2024; 23():15330338241241484. PubMed ID: 38725284
    [No Abstract]   [Full Text] [Related]  

  • 19. Roles of the Immune/Methylation/Autophagy Landscape on Single-Cell Genotypes and Stroke Risk in Breast Cancer Microenvironment.
    Wu JY; Qin J; Li L; Zhang KD; Chen YS; Li Y; Jin T; Xu JM
    Oxid Med Cell Longev; 2021; 2021():5633514. PubMed ID: 34457116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant endocrine therapy expands stromal populations that predict poor prognosis in estrogen receptor-positive breast cancer.
    Brechbuhl HM; Xie M; Kopin EG; Han AL; Vinod-Paul K; Hagen J; Edgerton S; Owens P; Sams S; Elias A; Sartorius CA; Tan AC; Kabos P
    Mol Carcinog; 2022 Mar; 61(3):359-371. PubMed ID: 34856027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.